Jose M. Trevejo's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 2,252 Common Stock done at an average price of $20 . Disclosure was reported to the exchange on Dec. 20, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 20 Dec 2023 | 2,252 | 2,251 | - | 20 | 45,040 | Common Stock |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 21 Mar 2023 | 529 | 6,572 | - | 12.6 | 6,687 | Common Stock |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.89 per share. | 21 Mar 2023 | 519 | 7,101 | - | 12.9 | 6,690 | Common Stock |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.15 per share. | 21 Mar 2023 | 465 | 6,107 | - | 12.2 | 5,650 | Common Stock |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 17 Mar 2023 | 530 | 7,620 | - | 12.6 | 6,683 | Common Stock |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 17 Mar 2023 | 504 | 8,150 | - | 13.3 | 6,693 | Common Stock |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 7,549 | 22,648 | - | - | Restricted Stock Units | |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 7,549 | 9,153 | - | - | Common Stock | |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.43 per share. | 15 Mar 2023 | 499 | 8,654 | - | 13.4 | 6,702 | Common Stock |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 45,459 | 45,459 | - | - | Stock Option (right to buy) | |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 30,792 | 30,792 | - | - | Restricted Stock Units | |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 116,424 | 116,424 | - | - | Employee Stock Option (right to buy) | |
Tarsus Pharmaceuticals Inc | Jose M. Trevejo | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 30,197 | 30,197 | - | - | Restricted Stock Units |